# Multi-cancer early detection in firefighters (Vincere Cancer Center)

Source: https://onco.cc/trials/vincere-firefighters-mced/  
OnCo record `vincere-firefighters-mced` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A US study testing two experimental multi-cancer tests, one on blood and urine sugars and one on blood proteins, in firefighters.

## Summary

Multi-cancer early detection in firefighters (NCT05780957) is an observational study sponsored by Vincere Cancer Center with Elypta, Proteotype. Its primary outcomes are sensitivity, specificity and predictive values of Elypta's test in plasma, urine and both, and of Proteotype's protein test in plasma.

The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 2,000 participants, a start on 21 March 2023 and primary completion expected on 31 December 2026.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Registry id: NCT05780957
- Phase: observational
- Setting: Firefighters in the United States, giving blood and urine to test Elypta's and Proteotype's multi-cancer tests
- Sponsor: Vincere Cancer Center with Elypta, Proteotype
- Enrolled: 2000

## Sources

- ClinicalTrials.gov NCT05780957: https://clinicaltrials.gov/study/NCT05780957

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [Elypta GAGome multi-cancer test](https://onco.cc/drugs/gagome-mced-test/)
- companies: [Elypta](https://onco.cc/companies/elypta/)

---
JSON: https://onco.cc/api/v1/entities/vincere-firefighters-mced.json